This JAMA Clinical Guidelines Synopsis summarizes the 2026 ACC/AHA guideline on the evaluation and management of dyslipidemia, covering recommended diagnostic and treatment approaches.
The source text provides only an abstract-level overview; specific recommendations, evidence grades, and supporting trial data are not available from this excerpt alone.
Clinicians managing lipid disorders should consult the full 2026 ACC/AHA dyslipidemia guideline for updated recommendations on screening, risk stratification, and treatment targets.
Explore related topics
